Veracyte to Present at Two Investor Conferences

On September 15, 2020 Veracyte, Inc. (Nasdaq: VCYT), a global genomic diagnostics company, reported that Bonnie H. Anderson, chairman and chief executive officer, is scheduled to participate in two virtual investor conferences this week (Press release, Veracyte, SEP 15, 2020, View Source [SID1234565171]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2020 Cantor Virtual Global Healthcare Conference
Presentation on Wednesday, September 16, 2020, at 1:20 p.m. ET
Lake Street’s Virtual 4th Annual (BIG4) Conference
1×1 meetings throughout the day on Thursday, September 17, 2020
A live audio webcast of the company’s presentation, where applicable, will be available by visiting Veracyte’s website at View Source Replays of the webcast will be available for 90 days following the conclusion of the live presentation broadcast.